ÂÜÀòÂÒÂ×

Matthias Jaffé is the Chief Financial Officer at Alpha-9 Theranostics Inc. Matthias has extensive experience in the biopharmaceutical industry, previously holding CFO positions at LogicBio Therapeutics, Constellation Pharmaceuticals, Zafgen, Pervasis Therapeutics, MTPV Corporation, and Alantos Pharmaceuticals. Matthias also worked as a Principal at Earlybird Venture Capital and as a Consultant at The Boston Consulting Group. Matthias holds a MBA in Accounting and Finance from INSEAD, a MS in Biology from Massachusetts Institute of Technology, and a BS in Chemistry from Universidad Simón Bolívar.